ArticleClinical lymphoma, myeloma & leukemia2019

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma.

Armin Ghobadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.